Low IGF1, and IGF1/IGFBP3 ratio may be associated with advanced liver fibrosis, while low levels of GH might have a role in hepatic steatosis in NAFLD [33,37]. Here, IGFBP3 is linked to metabolic dysfunction-associated steatotic liver disease.